Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRelx Share News (REL)

Share Price Information for Relx (REL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,582.00
Bid: 3,581.00
Ask: 3,582.00
Change: 10.00 (0.28%)
Spread: 1.00 (0.028%)
Open: 3,582.00
High: 3,615.00
Low: 3,578.00
Prev. Close: 3,572.00
REL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

RELX reports good start to 2021 for main businesses

Thu, 22nd Apr 2021 08:17

(Sharecast News) - RELX said it expected its three main businesses had started the year well but that the outlook was unclear for its exhibitions division with the Covid-19 pandemic continuing.
The analytics and information group reaffirmed its full-year outlook and said it expected trends to be similar to 2019. RELX shares rose 1.6% at 08:39 BST to £19.51 - their highest value since late February 2020.

The FTSE 100 company said its scientific, technical and medical division had good revenue growth from electronic products so far in 2021 and print revenue had stabilised. Underlying revenue will increase modestly with growth in underlying adjusted operating profit slightly stronger, it said.

The risk division will have strong revenue and profit growth after performance stepped up from mid-March, RELX said. Legal is set for a year of modest revenue growth and profit growth exceeding that rate.

Those three units make up 5% of 2020 revenue. The exhibitions business was hit by the Covid-19 crisis and has held 56 events so far in 2021, mainly in China and Japan. RELX said the pandemic would continue to affect physical events and the outlook was uncertain.

We continue to expect each of our three largest business areas ... to deliver another year of underlying revenue and adjusted operating profit growth in 2021, similar to pre-Covid-19 trends," RELX said in a statement before its annual general meeting. "The timing and pace of recovery in exhibitions remains uncertain."

More News
24 Jul 2020 09:38

UK BROKER RATINGS SUMMARY: Barclays Raises Phoenix And Cuts M&G

UK BROKER RATINGS SUMMARY: Barclays Raises Phoenix And Cuts M&G

Read more
23 Jul 2020 16:59

LONDON MARKET CLOSE: Unilever And Sage Help FTSE 100 Nudge Higher

LONDON MARKET CLOSE: Unilever And Sage Help FTSE 100 Nudge Higher

Read more
23 Jul 2020 16:04

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
23 Jul 2020 11:29

UK WINNERS & LOSERS SUMMARY: Hygiene Products Demand Boosts Unilever

UK WINNERS & LOSERS SUMMARY: Hygiene Products Demand Boosts Unilever

Read more
23 Jul 2020 09:13

LONDON MARKET OPEN: Unilever To Separate Tea Business; Holds Dividend

LONDON MARKET OPEN: Unilever To Separate Tea Business; Holds Dividend

Read more
23 Jul 2020 09:04

TOP NEWS: Relx Interim Profit Plunges; Outlook Remains Uncertain

TOP NEWS: Relx Interim Profit Plunges; Outlook Remains Uncertain

Read more
23 Jul 2020 07:57

Relx exhibitions division swings to interim loss due to Covid-19

(Sharecast News) - Relx - formerly Reed Elsevier - reported a 10% fall in interim revenue on Thursday as the Covid-19 pandemic weighed on the company's exhibitions business.

Read more
23 Jul 2020 07:54

LONDON MARKET PRE-OPEN: RELX Hold Dividend As Covid-19 Hits Earnings

LONDON MARKET PRE-OPEN: RELX Hold Dividend As Covid-19 Hits Earnings

Read more
23 Jul 2020 07:37

UPDATE 2-Relx sales fall as virus hits events business

(Adds CFO comments, analyst reaction, shares)By Pushkala Aripaka and Paul SandleJuly 23 (Reuters) - European information group Relx said on Thursday its revenue fell 10% in the first half of the year as the coronavirus pandemic halted public meetin...

Read more
15 Jul 2020 09:49

UK BROKER RATINGS SUMMARY: Goldman Starts Glencore With Buy Rating

UK BROKER RATINGS SUMMARY: Goldman Starts Glencore With Buy Rating

Read more
3 Jul 2020 13:15

Friday broker round-up

(Sharecast News) - Next: Goldman Sachs downgrades to sell with a target price of 4,400.0p.

Read more
3 Jul 2020 09:40

UK BROKER RATINGS SUMMARY: Goldman Lowers Ratings On AB Foods And Next

UK BROKER RATINGS SUMMARY: Goldman Lowers Ratings On AB Foods And Next

Read more
30 Jun 2020 10:59

UK WINNERS & LOSERS SUMMARY: Shell Sinks As It Warns On Oil Price Hit

UK WINNERS & LOSERS SUMMARY: Shell Sinks As It Warns On Oil Price Hit

Read more
30 Jun 2020 09:31

UK BROKER RATINGS SUMMARY: Exane BNP Downgrades RELX To Underperform

UK BROKER RATINGS SUMMARY: Exane BNP Downgrades RELX To Underperform

Read more
30 Jun 2020 08:48

LONDON MARKET OPEN: Stocks Down As Shell To Take USD22 Billion Hit

LONDON MARKET OPEN: Stocks Down As Shell To Take USD22 Billion Hit

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.